5The Sicilian gambit. A new approach to the classification of antiarrythmic drugs based on their actions on arrhythmogenic mechanisms[J]. Circulation, 1991, 84 ( 12) : 1831-1851.
6Brugada P. The Vaughan-Williams classification of antiarrhythmic drugs. Why don't we find its clinical counterpart?[J]. Pacing Clin Electrophysiol , 1990, 13 (3) : 339-343.
7Haugh K H. Antidysrhythmic agents at the turn of the twenty-first century: a current review[l]. Crit Care Nurs Clin North Am, 2002, 14 ( 1 ) : 53-69.
8Packer D L, Kowal R C, Wheelan K R, et al. Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial Fibrillation: First Results of the North American Arctic Front (STOP AF) Pivotal Trial[J]. J Am Coll Cardiol, 2013, 61 ( 16): 1713-1723.
9Giugliano R P, Braunwald E. 2004 ACC/AHA guideline for the management of patients with STEMI: The implications for clinicians[J]. Nat Clin Peact Cardiovasc Med, 2005, 2 (3): 114-115.
10Bonow R 0, Bennett S, Casey DE Jr, et al. ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) : Endorsed by the Heart Failure Society of America[J]. Circulation, 2005, 112 (12) : 1853- 1887.
